Navigation Links
Phase III data show significant reduction in blood glucose with investigational compound empagliflozin added to metformin or metformin plus sulfonylurea in adults with type 2 diabetes
Date:6/22/2013

e global operations. Mutual cooperation and respect, as well as environmental protection and sustainability are intrinsic factors in all of Boehringer Ingelheim's endeavors.

In 2012, Boehringer Ingelheim achieved net sales of about $19.1 billion (14.7 billion euro). R&D expenditure in the business area Prescription Medicines corresponds to 22.5 percent of its net sales. For more information please visit www.us.boehringer-ingelheim.com.

About Eli Lilly and Company
Lilly, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, IN, Lilly provides answers – through medicines and information – for some of the world's most urgent medical needs. Additional information about Lilly is available at www.lilly.com.

About Lilly Diabetes
Lilly has been a global leader in diabetes care since 1923, when we introduced the world's first commercial insulin. Today we work to meet the diverse needs of people with diabetes through research and collaboration, a broad and growing product portfolio and a continued commitment to providing real solutions – from medicines to support programs and more – to make lives better.

For more information, visit www.lillydiabetes.com.

P-LLY
DIA568105PR

This press release contains forward-looking statements about empagliflozin* for the treatment of type 2 diabetes. It reflects Lilly's current beliefs; however, as with any such undertaking, there are substantial risks and uncertainties in the process of drug development and commercialization. There is no guarantee that future study results and patient exp
'/>"/>

SOURCE Eli Lilly and Company; Boehringer Ingelheim Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
2. Anthera Announces the Completion of Patient Dosing in Phase 2b PEARL-SC Study
3. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
4. Retrospective Study Suggests that Stereotactic Ablative Radiotherapy (SABR) Can be a Viable Option for Treating Early-Stage Lung Cancer in Operable as well as Inoperable Patients; Phase III Randomized Trial Now Under Way
5. Ultragenyx Announces Phase 1 Results of UX001 in Hereditary Inclusion Body Myopathy (HIBM), a Rare Neuromuscular Disease
6. Lexicon Receives Funding for Phase 2 Clinical Trial of LX4211 in Type 1 Diabetes
7. Isis Initiates Phase 2 Study of ISIS-APOCIIIRx in Patients with Hypertriglyceridemia
8. Alder BioPharmaceuticals Inc. Initiates Phase 1 Clinical Study of Antibody Therapeutic Candidate for Treatment of Migraine, ALD403
9. Results Reported for Phase Ib Open-Label Clinical Trial for the Treatment of Depression Using External Trigeminal Nerve Stimulation (eTNS™) - The USB Port to the Brain™
10. Pearl Therapeutics Phase 2b Twice-Daily Dosing Data Suggest Morning and Evening Benefit of PT003 in Patients with COPD
11. Adamas Pharmaceuticals Announces Successful End-of-Phase 2 Meeting with FDA for Arimenda™
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... Aug. 29, 2014 Diseases largely eradicated in ... ago are returning. Measles was declared eliminated in 2000, ... as of August 15—the highest incidence in 20 years. ... department declared whooping cough a problem of "epidemic ... sick and dying from these preventable diseases—in part because ...
(Date:8/29/2014)... -- In part four of a blog series ... a strategic asset, Mary Baxter, MBA, RPh ., ... Innovation Delivery Solutions business, discusses how expanding patient access ... patients. "Every hospital pharmacist knows that filling ... in a value-based healthcare world," Baxter says. "For the ...
(Date:8/29/2014)... , August 29, 2014 Pixcelldata, ... collaboration software has announced a major new deal with ... by renowned pathology expert, Dr. Marius Nap . ... the 26th European Congress of Pathology which is taking ... ExCeL Arena, London where Pixcelldata ...
Breaking Medicine Technology:Vaccines at the Crossroads: Outbreaks On the Rise Across America 2Vaccines at the Crossroads: Outbreaks On the Rise Across America 3Five Ways Hospital Pharmacies Can Fulfill Their Quality Care Mission 2Five Ways Hospital Pharmacies Can Fulfill Their Quality Care Mission 3Five Ways Hospital Pharmacies Can Fulfill Their Quality Care Mission 4Pixcelldata Announces New Deal with Dutch Tele-Pathology Specialists eX-Path Ahead of ECP 2014 2
... CHARLOTTE, N.C., Sept. 11 In a new ... able to receive a promising,investigational ultrasound treatment option., ... in Urology, located in North,Naples, FL, is investigating ... (HIFU) for the treatment of locally recurrent prostate,cancer ...
... Sept. 11 Vanda,Pharmaceuticals Inc. (Nasdaq: VNDA ... commercialization of clinical-stage product candidates,for central nervous system ... on September 10, 2008 and discuss the iloperidone ... 25, 2008., Vanda presented arguments to support ...
Cached Medicine Technology:High Intensity Focused Ultrasound for Locally Recurrent Prostate Cancer Following External Beam Radiation Therapy Investigated in Phase III Clinical Study 2Vanda Pharmaceuticals Provides Update on Iloperidone 2Vanda Pharmaceuticals Provides Update on Iloperidone 3
(Date:8/31/2014)... (PRWEB) August 31, 2014 Ticket Down ... in Miami, FL at the Sun Life Stadium in early ... additional savings. , The game on September 5th between Colombia and ... Stadium. The match last year between Brazil and Honduras at Sun ... Stadium opened in 1987 and has also been the home of ...
(Date:8/31/2014)... UWDress.com, a renowned wedding dress manufacturer and ... of elegant formal bridesmaid dresses today. Moreover, ... high quality special occasion outfits. All its current and ... off). , Along with the greatly discounted prices, ... company’s promotional formal bridesmaid outfits are offered in over ...
(Date:8/31/2014)... Recently, iFitDress.com, a well-known wedding dress manufacturer ... bridesmaid dresses for 2014. What’s more, the firm has ... outfits; all people can enjoy a low rate (up to ... from this afternoon until September 12. , “We are ... for customers from home and abroad. The main purpose of ...
(Date:8/31/2014)... Utah (PRWEB) August 31, 2014 ... which recognizes innovation in dietary supplements, has picked ... finalists in the Weight Management category. This nomination ... developing and marketing products that can support healthy ... sensible exercise program. , NutriGold’s weight-loss product includes ...
(Date:8/31/2014)... Market Research Report on ... 2009-2019 is a professional and in-depth market ... Equipment industry. The report firstly reviews the ... its classification, application and manufacturing technology. , ... top manufacturers of Portable Laboratory Equipment listing ...
Breaking Medicine News(10 mins):Health News:Brazil vs. Colombia Tickets in Miami: Ticket Down Slashes Colombia vs. Brazil Tickets at Sun Life Stadium in Miami for September 5th Match 2Health News:Brazil vs. Colombia Tickets in Miami: Ticket Down Slashes Colombia vs. Brazil Tickets at Sun Life Stadium in Miami for September 5th Match 3Health News:Elegant Formal Bridesmaid Dresses Today Unveiled By UWDress.com 2Health News:Gorgeous Bridesmaid Dresses For 2014 Now Offered By iFitDress.com 2Health News:NutriGold’s Weight-loss Product Honored with a SupplySide Editor’s Choice Awards Nomination 2Health News:NutriGold’s Weight-loss Product Honored with a SupplySide Editor’s Choice Awards Nomination 3Health News:Portable Laboratory Equipment Industry for Global and Chinese Market Forecasts to 2019 in New Research Report Available at ReportsnReports.com 2Health News:Portable Laboratory Equipment Industry for Global and Chinese Market Forecasts to 2019 in New Research Report Available at ReportsnReports.com 3Health News:Portable Laboratory Equipment Industry for Global and Chinese Market Forecasts to 2019 in New Research Report Available at ReportsnReports.com 4
... ... , ... May 25, 2010 -- Today Jolly Technologies announces the public release of ID Flow version ... amounts of data (up to billions of records), direct support for flash cameras and automatic ...
... ... announced today the availability of a position paper revealing how health IT leaders can ... and facilities through collaboration and clinical quality improvement strategies. , ... Scottsdale, AZ (Vocus) May 25, 2010 -- ...
... ... who Suffers from a Vision-Robbing Condition called Retinitis Pigmentosa , ... Brandywine, MD (PRWEB) -- The students of Baden Elementary ... funds for the Foundation Fighting Blindness . The event was organized by Baden sixth ...
... ... digital self-publishing platform (DBook) that allows corporations, educational institutions, publishers and writers to easily ... , ... May 25, 2010 -- WebPublished today announced the launch of the first rich ...
... ... friendly oil leak containment system. , ... West Palm Beach, FL (PRWEB) May 25, 2010 -- Golden ... of Palm Beach County LLC have entered into a strategic alliance. JK Development ...
... predisposition to delivering early, , MONDAY, May 24 (HealthDay News) ... to give birth to a baby who isn,t full-term, a ... who weren,t born early but had one or more siblings ... researchers. , "There was a suspicion that preterm birth might ...
Cached Medicine News:Health News:Jolly Announces the Release of ID Flow 5.0 2Health News:Expert Insights on Health Data Sharing, Collaboration, Quality and Meaningful Use Featured in Latest Carefx Position Paper 2Health News:Expert Insights on Health Data Sharing, Collaboration, Quality and Meaningful Use Featured in Latest Carefx Position Paper 3Health News:Baden Elementary School holds VisionWalk to Fight Blindness 2Health News:Baden Elementary School holds VisionWalk to Fight Blindness 3Health News:WebPublished Launches Dynamic Rich Expressive Digital Publishing Platform for Digital Textbook or Magazine Publishers 2Health News:WebPublished Launches Dynamic Rich Expressive Digital Publishing Platform for Digital Textbook or Magazine Publishers 3Health News:Golden Age Resources, Inc. Announces Strategic Alliance with JK Development of Palm Beach County LLC in an Attempt to Stop the Oil Leak in the Gulf 2Health News:Women Born Early More Apt to Have Preterm Baby 2
... based on sequential binding of HCG from ... for the *-chain of HCG) immobilized on ... the *-chain of HCG) conjugated to the ... chromogenic substrate is added and colors developed. ...
For the quantitative determination of Glycohemoglobin in blood....
... the main storage protein for iron. The ... (apoferritin) composed of heavy and light subunits, ... oxide and phosphate [1]. Ferritin is synthesized ... body tissues, with major concentrations found in ...
...
Medicine Products: